Bexarotene gel well-tolerated treatment for plaque psoriasis

Article

The treatment was well tolerated. Most adverse events were mild and consisted primarily of irritation or erythema at the site of application.

Related Videos
Related Content

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023

Discovering Dermatology Times: September 2023 BCC Management Supplement

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Incyte to Present Numerous Studies at EADV 2023

September 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline

September 29th 2023

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

September 29th 2023
© 2023 MJH Life Sciences

All rights reserved.